Epigenetic mechanisms of gene regulation in amyotrophic lateral sclerosis
Despite being clinically described 150 years ago, the mechanisms underlying amyotrophic
lateral sclerosis (ALS) pathogenesis have not yet been fully understood. Studies in both …
lateral sclerosis (ALS) pathogenesis have not yet been fully understood. Studies in both …
[HTML][HTML] The cellular and molecular signature of ALS in muscle
Amyotrophic lateral sclerosis is a disease affecting upper and lower motor neurons.
Although motor neuron death is the core event of ALS pathology, it is increasingly …
Although motor neuron death is the core event of ALS pathology, it is increasingly …
Amyotrophic lateral sclerosis (motor neuron disease): proposed mechanisms and pathways to treatment
EF Goodall, KE Morrison - Expert reviews in molecular medicine, 2006 - cambridge.org
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterised by
loss of motor neurons. The cause of disease is unknown other than in the rare cases of …
loss of motor neurons. The cause of disease is unknown other than in the rare cases of …
Opinion: more mouse models and more translation needed for ALS
EMC Fisher, L Greensmith, A Malaspina… - Molecular …, 2023 - Springer
Amyotrophic lateral sclerosis is a complex disorder most of which is 'sporadic'of unknown
origin but approximately 10% is familial, arising from single mutations in any of more than 30 …
origin but approximately 10% is familial, arising from single mutations in any of more than 30 …
Current view and perspectives in amyotrophic lateral sclerosis
S Mathis, P Couratier, A Julian, P Corcia… - Neural Regeneration …, 2017 - journals.lww.com
Amyotrophic lateral sclerosis (ALS), identified as a distinct clinical entity by Charcot since the
end of the nineteenth century, is a devastating and fatal neurodegenerative disorder that …
end of the nineteenth century, is a devastating and fatal neurodegenerative disorder that …
Metabolic dysregulation in amyotrophic lateral sclerosis: challenges and opportunities
A Joardar, E Manzo, DC Zarnescu - Current genetic medicine reports, 2017 - Springer
Abstract Purpose of Review Amyotrophic lateral sclerosis (ALS) is a progressive
neurodegenerative disease for which there is no cure and treatments are at best palliative …
neurodegenerative disease for which there is no cure and treatments are at best palliative …
Drug discovery and amyotrophic lateral sclerosis: Emerging challenges and therapeutic opportunities
P Soares, C Silva, D Chavarria, FSG Silva… - Ageing Research …, 2023 - Elsevier
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of upper and lower
motor neurons (MNs) leading to paralysis and, ultimately, death by respiratory failure 3–5 …
motor neurons (MNs) leading to paralysis and, ultimately, death by respiratory failure 3–5 …
Therapeutic approaches targeting protein aggregation in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative disease that targets
motor neurons (MNs) in the brain and spinal cord. It leads to gradual loss of motor signals to …
motor neurons (MNs) in the brain and spinal cord. It leads to gradual loss of motor signals to …
The glutamate hypothesis in ALS: pathophysiology and drug development
H Blasco, S Mavel, P Corcia… - Current medicinal …, 2014 - ingentaconnect.com
Amyotrophic lateral sclerosis (ALS) is an age-related neurodegenerative disorder that is
believed to have complex genetic and environmental influences in the pathogenesis, but …
believed to have complex genetic and environmental influences in the pathogenesis, but …
[HTML][HTML] Amyotrophic lateral sclerosis: an update for 2013 clinical features, pathophysiology, management and therapeutic trials
PH Gordon - Aging and disease, 2013 - ncbi.nlm.nih.gov
Amyotrophic lateral sclerosis (ALS), first described by Jean-Martin Charcot in the 1870s, is
an age-related disorder that leads to degeneration of motor neurons. The disease begins …
an age-related disorder that leads to degeneration of motor neurons. The disease begins …